Glutamine

Glutamine

SCHEMBL104313

C[C@H](N)C(=O)O.NC(=O)CC[C@H](N)C(=O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.83
PMP22 Q01453 2/20 0.83
ALOX15 P16050 1/20 0.83
BLM P54132 1/20 0.83
CYP1A2 P05177 3/20 0.58
GSR P00390 2/20 0.58
SLC1A3 P43003 2/20 0.58
SLC1A2 P43004 2/20 0.58
SLC1A1 P43005 2/20 0.58
GRM8 O00222 1/20 0.58
GRM6 O15303 1/20 0.58
GRIN2D O15399 1/20 0.58
GRIN3B O60391 1/20 0.58
GRIK1 P39086 1/20 0.58
GRM5 P41594 1/20 0.58
GRIA1 P42261 1/20 0.58
GRIA2 P42262 1/20 0.58
GRIA3 P42263 1/20 0.58
GRIA4 P48058 1/20 0.58
GRIN1 Q05586 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamine SCHEMBL432398 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2
Glutamine SCHEMBL6555864 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2
Glutamine SCHEMBL3688684 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2
Glutamine SCHEMBL5848376 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2
Glutamine SCHEMBL3059857 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2
Glutamine SCHEMBL14485584 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2
Glutamine SCHEMBL4613452 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2
Glutamine SCHEMBL5085797 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2
Glutamine SCHEMBL20553625 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2
Glutamine SCHEMBL11170132 1.00 KMT2A (0.83) KMT2APMP22ALOX15BLMCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 618 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361479-A1 CELL CULTURE MEDIUM REGENERON PHARMACEUTICALS, INC. (US) 2025-11-27 US claimed
EP-3277083-B1 USE OF AN ORGAN PRESERVATION COMPOSITION FOR THE PRESERVATION OF AN ORGAN OR PARTS THEREOF VIVALYX GMBH (DE) 2025-01-22 EP claimed
EP-4476327-A1 METHODS AND COMPOSITIONS FOR GENERATING HUMAN INDUCED MESENCHYMAL STEM CELLS SmartCella Solutions AB (SE) 2024-12-18 EP claimed
CN-119032932-A Frozen stock solution for tissues and preparation method thereof 启载生物科技(成都)有限公司 2024-11-29 CN claimed
CN-118660954-A Method for culturing immune cells 莱尔免疫制药公司 2024-09-17 CN claimed
EP-4423249-A1 METHODS FOR CULTURING IMMUNE CELLS Lyell Immunopharma, Inc. (US) 2024-09-04 EP claimed
CN-118541473-A Compositions and methods for culturing stem cells 北京思珞赛生物科技有限公司 2024-08-23 CN claimed
US-20240228957-A9 METHODS FOR CULTURING CELLS LYELL IMMUNOPHARMA, INC. (US) 2024-07-11 US claimed
CN-118272305-A Immune cell culture medium and application thereof 深圳泽医细胞治疗集团有限公司 2024-07-02 CN claimed
CN-118240758-A Immune cell culture medium and application thereof 深圳泽医细胞治疗集团有限公司 2024-06-25 CN claimed
US-20130259834-A1 COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC PEPTIDES UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2013-10-03 US claimed
EP-2571894-A1 COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC PEPTIDES North Carolina State University (US) 2013-03-27 EP claimed
WO-2011146715-A1 COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC PEPTIDES NORTH CAROLINA STATE UNIVERSITY (US) 2011-11-24 WO claimed
US-7977096-B2 Stem cell growth media and methods of making and using same CALIFORNIA STEM CELL, INC. (US) 2011-07-12 US claimed
EP-2115125-A2 STEM CELL GROWTH MEDIA AND METHODS OF MAKING AND USING SAME California Stem Cell, Inc. (US) 2009-11-11 EP claimed
US-20090035860-A1 STEM CELL GROWTH MEDIA AND METHODS OF MAKING AND USING SAME CALIFORNIA STEM CELL, INC. (US) 2009-02-05 US claimed
WO-2008085879-A2 STEM CELL GROWTH MEDIA AND METHODS OF MAKING AND USING SAME CALIFORNIA STEM CELL, INC. (US) 2008-07-17 WO claimed
EP-0906333-B1 SUBSTRATES AND INHIBITORS OF PROTEOLYTIC ENZYMES MEDIVIR UK LTD (GB) 2001-07-25 EP claimed
US-5561111-A Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 1996-10-01 US claimed
US-4534881-A Inhibition of inorganic or biological CaCO3 deposition by poly amino acid derivatives UNIVERSITY OF SOUTH ALABAMA (US) 1985-08-13 US claimed